Search

everythinglearnresearchcommunity

for

Search:↓

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Serum triglyceride levels are not linked to prostate cancer risk.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Alopecia linked to higher anxiety and personality disorders.

Early balding men may have insulin resistance, but lifestyle changes can help.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The Rotterdam Study aims to understand various diseases in older adults.